Alzheimer’s “wonder drugs” do not work, scientists have found in a study that overturns decades of research into the disease.

UCF researchers have uncovered evidence that some movement-related symptoms of Alzheimer's disease may originate outside the ...

The secret might be hidden in our blood. Boston researchers in a new study have found that a blood test can predict Alzheimer’s disease progression years before symptoms or brain scan changes. The ...

A systematic review suggested that drugs targeting amyloid beta appeared to have no clinically meaningful positive effects, ...

A new medical review finds "trivial" benefits for amyloid drugs. See why U.S. experts say these findings may not tell the ...

Does Alzheimer’s start in the muscles? Research reveals that motor neuron mutations disrupt the neuromuscular junction independent of the brain.

A new study from Mass General Brigham suggests a blood test may detect early biological signs of Alzheimer’s disease earlier ...

The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, ...

Alzheimer's Society responds to the claim that amyloid-targeting drugs show no clinically meaningful positive effects.

Critics say the meta-analysis provides an inaccurate picture of anti-amyloid medications. Two of them have FDA approval.

Drugs once hailed as a breakthrough in the fight against Alzheimer's disease do not meaningfully help patients, a major ...

For the millions of families watching a loved one slip away to Alzheimer’s disease, the arrival of drugs that promised to ...